Csaba P. Kövesdy

机构：University of Tennessee Health Science Center, Experimental Station for the Industry of the Essential Oils and Citrus Products, Memphis VA Medical Center, Diabetes Care Center · ORCID：0000-0002-8204-911X

发表论文 1024 篇 · 总被引 72253 次 · h-index 126

代表论文

• Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals (2026 · Nature Medicine · 被引 10)
• Lipid-Lowering Therapies in Patients with Chronic Kidney Disease: A Perspective on High-Density Lipoprotein Cholesterol (2026 · Drugs · 被引 5)
• Please Tell Me It Is Only a Nightmare—The Proposed Dismantling of the United States Federal Research Infrastructure (2026 · Diabetes Care · 被引 3)
• The obesity and lipid paradoxes in chronic kidney disease: mechanisms, interventions, and future directions (2025 · Current Opinion in Nephrology & Hypertension · 被引 2)
• Nondialytic Care vs Dialysis Transition on Hospitalization: Outcomes in Veterans With Advanced Chronic Kidney Disease (2026 · Mayo Clinic Proceedings · 被引 1)
• Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure (2026 · Hypertension · 被引 1)